Abstract:Cyclin-dependent kinase like 5 (CDKL5) is a serine-threonine kinase highly enriched in mammalian neurons. CDKL5 is located on the X-chromosome and its loss-of-function leads to a severe neurodevelopmental disorder called CDKL5 deficiency disorder (CDD). CDKL5 phosphorylates microtubule-associated protein MAP1S and regulates its binding to microtubules. How MAP1S phosphorylation affects microtubule function is not well understood. To address this question, we generated MAP1S phosphomutant mice, in which the CDKL5 phosphorylation sites S786 and S812 are mutated to Alanine (MAP1S S786/812A or MAP1S SA). Using a microtubule co-sedimentation assay, we showed that dynein binding to microtubules is severely reduced in CDKL5 knockout (KO) and MAP1S SA brains. Time-lapse imaging in primary neurons showed impaired dynein motility in both Cdkl5 KO and MAP1S SA. Dynein-driven cargo transport was affected in mutant neuron dendrites, including the delivery of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. We next studied tubulin tyrosination in Cdkl5 KO and MAP1S SA neurons and found that both mutants had a reduced tubulin tyrosination when compared to WT neurons. Since dynein-dynactin has a higher affinity for tyrosinated microtubules, we hypothesized that reduced tyrosination in MAP1S phosphomutant mice could be the mechanistic cause of impaired dynein motility. In support of this, we show that upon expression of tubulin tyrosine kinase TTL, we rescued dynein motility defects in MAP1S phosphomutant neurons. Hippocampal neurons derived from MAP1S SA mice revealed a significant reduction in spine density and synapses, and altered spine morphology. Finally, behavioral phenotyping of MAP1S phosphomutant mice showed increased anxiety, impaired motor performance, social and memory deficits, mirroring to some extent the clinical manifestations present in CDD patients. Our results reveal MAP1S phosphorylation to be an important contributor to dynein-mediated transport and synapse formation.

Serine 176 Phosphorylation Attenuates Kinesin'S Stall Force and Biases Bidirectional Transport

Motor Domain Phosphorylation Modulates Kinesin-1 Transport*

Potential Phosphorylation Site Modulates the Dimerization and Activity of Kif1a

Pathogenic Mutations in the Kinesin-3 Motor KIF1A Diminish Force Generation and Movement Through Allosteric Mechanisms

Force generation of KIF1C is impaired by pathogenic mutations

Kinesin Autoinhibition Requires Elbow Phosphorylation

Effect of spastic paraplegia mutations in KIF5A kinesin on transport activity

Huntingtin Phosphorylation Acts As A Molecular Switch for Anterograde/Retrograde Transport in Neurons

Kinesin-1-syntaphilin coupling mediates activity-dependent regulation of axonal mitochondrial transport.

Tubulin CFEOM mutations both inhibit or activate kinesin motor activity

A Multiscale approach reveals the molecular architecture of the autoinhibited kinesin KIF5A

A force-sensitive mutation reveals a non-canonical role for dynein in anaphase progression

UNC-104 transport properties are robust and independent of changes in its cargo binding

DNA tensiometer reveals catch-bond detachment kinetics of kinesin-1, -2 and -3

Characterizing human KIF1Bβ motor activity by single-molecule motility assays and Caenorhabditis elegans genetics

Role of Ser50 phosphorylation in SCG10 regulation of microtubule depolymerization

Single Molecule Investigation of Kinesin-1 Motility Using Engineered Microtubule Defects

Serine Phosphorylation Negatively Regulates RhoA in Vivo

Phosphorylation of human cardiac troponin I G203S and K206Q linked to familial hypertrophic cardiomyopathy affects actomyosin interaction in different ways.

CDKL5's role in microtubule-based transport and cognitive function

Mechanism of Ser88 phosphorylation-induced dimer dissociation in dynein light chain LC8.